Suppr超能文献

2020年6月至2021年5月中国无症状感染者引起的7起新冠肺炎疫情病例系列的流行病学特征及差异化管理策略

Epidemiologic characteristics and differential management strategies of seven case series with COVID-19 outbreaks caused by asymptomatic carriers from June 2020 to May 2021 in China.

作者信息

Liu Cheng, Xiang Hongbing, Manyande Anne, Xu Weiguo, Fan Li, Zhang Yunhua, Xiang Boqi

机构信息

Department of Anesthesiology and Pain Medicine, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology Wuhan 430030, Hubei, P. R. China.

School of Human and Social Sciences, University of West London London, United Kingdom.

出版信息

Am J Transl Res. 2022 Apr 15;14(4):2244-2255. eCollection 2022.

Abstract

With the COVID-19 epidemic quickly under control in China in the early stage of 2020, global cooperation/communications may pose great challenges to epidemic control and prevention in the country. Large-scale spread by asymptomatic carriers was a concern. We obtained data on new cluster outbreak regions with COVID-19 caused by asymptomatic carriers from June 2020 to May 2021 in China, and reported the epidemiological characteristics, the possible routes of viral transmission and infection, and different control strategies. These results show the importance of regular screening for high-risk populations and differential management strategies for epidemic control, which provide an objective basis for suppressing the spread of the SARS-CoV-2 virus. These experiences can be used as a reference to minimize the subsequent spread of virus mutants in various places.

摘要

2020年初,随着中国境内新冠疫情迅速得到控制,全球合作/交流可能给该国的疫情防控带来巨大挑战。无症状感染者引发的大规模传播令人担忧。我们获取了2020年6月至2021年5月中国境内由无症状感染者导致的新冠疫情新聚集性暴发地区的数据,并报告了其流行病学特征、病毒传播和感染的可能途径以及不同的防控策略。这些结果表明了对高危人群进行定期筛查以及采取差异化管理策略进行疫情防控的重要性,为抑制严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒传播提供了客观依据。这些经验可作为参考,以尽量减少病毒变异株在各地的后续传播。

相似文献

2
Transmission Routes Analysis of SARS-CoV-2: A Systematic Review and Case Report.
Front Cell Dev Biol. 2020 Jul 10;8:618. doi: 10.3389/fcell.2020.00618. eCollection 2020.
6
A study on infectivity of asymptomatic SARS-CoV-2 carriers.
Respir Med. 2020 Aug;169:106026. doi: 10.1016/j.rmed.2020.106026. Epub 2020 May 13.
7
[Experience and thinking on the normalization stage of prevention and control of COVID-19 in China].
Zhonghua Yi Xue Za Zhi. 2021 Mar 16;101(10):695-699. doi: 10.3760/cma.j.cn112137-20210104-00008.
8
Clinical characteristics and infectivity of asymptomatic carriers of SARS-CoV-2 (Review).
Exp Ther Med. 2021 Feb;21(2):115. doi: 10.3892/etm.2020.9547. Epub 2020 Dec 3.
9
Coronavirus disease 2019: reassembly attack of coronavirus.
Int J Environ Health Res. 2022 Feb;32(2):243-251. doi: 10.1080/09603123.2020.1747602. Epub 2020 Apr 21.

引用本文的文献

本文引用的文献

1
Brain Imaging Changes in Patients Recovered From COVID-19: A Narrative Review.
Front Neurosci. 2022 Apr 22;16:855868. doi: 10.3389/fnins.2022.855868. eCollection 2022.
3
Cold-chain food contamination as the possible origin of COVID-19 resurgence in Beijing.
Natl Sci Rev. 2020 Oct 23;7(12):1861-1864. doi: 10.1093/nsr/nwaa264. eCollection 2020 Dec.
6
Transmissibility and transmission of respiratory viruses.
Nat Rev Microbiol. 2021 Aug;19(8):528-545. doi: 10.1038/s41579-021-00535-6. Epub 2021 Mar 22.
7
Geographical and Epidemiological Characteristics of 3,487 Confirmed Cases With COVID-19 Among Healthcare Workers in China.
Front Public Health. 2021 Jan 26;8:586736. doi: 10.3389/fpubh.2020.586736. eCollection 2020.
8
A robust pooled testing approach to expand COVID-19 screening capacity.
PLoS One. 2021 Feb 8;16(2):e0246285. doi: 10.1371/journal.pone.0246285. eCollection 2021.
9
Asymptomatic SARS-CoV-2 Carriers: A Systematic Review and Meta-Analysis.
Front Public Health. 2021 Jan 20;8:587374. doi: 10.3389/fpubh.2020.587374. eCollection 2020.
10
Modeling the transmission of COVID-19 in the US - A case study.
Infect Dis Model. 2020 Dec 30;6:195-211. doi: 10.1016/j.idm.2020.12.006. eCollection 2021.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验